Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.19
Delayed Data
As of 4:00pm ET
 +0.15 / +2.98%
Today’s Change
3.92
Today|||52-Week Range
8.38
+11.61%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$684.1M

Company Description

Keryx Biopharmaceuticals, Inc. engages in the manufacture, development, and commercialization of medicines for use in treating human diseases. Its product is the Auryxia tablet. The company was founded in October 1998 and is headquartered in Boston, MA.

Contact Information

Keryx Biopharmaceuticals, Inc.
12th Floor
Boston Massachusetts 02210
P:(617) 466-3500
Investor Relations:
(617) 466-3511

Employees

Shareholders

Other institutional71.11%
Mutual fund holders22.38%
Individual stakeholders13.47%

Top Executives

Jodie P. MorrisonChief Executive Officer & Director
Christine A. CarberryChief Operating Officer & Senior Vice President
Scott A. HolmesCFO, Principal Accounting Officer & Senior VP
John F. NeylanChief Medical Officer & Senior Vice President
Melissa Bradford-KlugChief Business Officer & Senior Vice President